We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for health professionals on the epidemiology, transmission and prevention of Chlamydia abortus which can cause stillbirth or abortion in humans.
What you can do to help reduce the risk of bovine tuberculosis (TB) infection in your herd.
Apply for funding for community projects that prevent hate crime.
Find out how you could do the SFI actions for hedgerows.
How businesses and organisations can avoid causing pollution from oil and chemical storage, car washing, construction and other activities.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Privacy notice for patients participating in surgical site infection surveillance.
New 10-year plan to expand and improve the drug and alcohol workforce published.
Using an ecological momentary assessment to evaluate your digital health product.
How to stop harmful weeds spreading onto land used for grazing livestock or growing crops, how to dispose of them and how to report them if they’ve spread.
How to spot epizootic haemorrhagic disease, what to do if you suspect it and measures to prevent its spread.
Discrimination policy and equal opportunities in recruitment and in the workplace - age discrimination, disabled workers, gender reassignment, sex discrimination
How to use a randomised controlled trial to evaluate your digital health product.
The MHRA has authorised cabotegravir as 30 mg tablets and as a 600 mg long-acting injection administered every two months
How to spot equine viral arteritis, what to do if you suspect it and measures to prevent its spread.
Climate change is happening and is due to human activities; along with warming, many other changes are occurring such as melting polar ice, rising sea levels and more frequent floods, droughts and heatwaves.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).